Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients

何幸穎、賴學洲、賴明美、賴世偉、林文元、林獻峰、林志學、劉秋松、林璨（2006）。Relationship between Nonalcoholic Fatty Liver and the Components of Metabolic Syndrome: A Hospital-based Study。Mid-Taiwan Journal of Medicine，11(1)，35-41。https://doi.org/10.6558/MTJM.2006.11(1).5
Hong, K. S., Son, J. W., Ryu, O. H., Choi, M. G., Hong, J. Y., & Lee, S. J. (2016). Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer. International Journal of Endocrinology, 2016(), 468-473-153. https://doi.org/10.1155/2016/9846790
蘇富敏、張榮參（2006）。Short-termed Efficacy of Ursodeoxycholic Acid (UDCA) in Patients with Chronic Hepatitis。台灣醫學，10(6)，695-704。https://doi.org/10.6320/FJM.2006.10(6).04
Xiao, J., So, K. F., Liong, E. C., & Tipoe, G. L. (2013). Recent Advances in the Herbal Treatment of Non-Alcoholic Fatty Liver Disease. Journal of Traditional and Complementary Medicine, 3(2), 88-94. https://doi.org/10.4103/2225-4110.110411
Tacer, K. F., & Rozman, D. (2011). Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation. Journal of Lipids, 2011(), 390-403. https://doi.org/10.1155/2011/783976